Deaths from advanced lung cancer have dropped significantly since immunotherapy became standard-of-care.

The Cochrane Library.The single most reliable source of evidence in healthcareThe Cochrane Reviews highlighted below are available from the Cochrane Database of Systematic Reviews (www.thecochranelibrary.com) Cochrane Reviews are regularly updated as new evidence emerges and in response to feedback, and the Cochrane Database of Systematic Reviews should always be consulted for the most recent version of the review. Deaths from advanced lung cancer have dropped significantly since immunotherapy became standard-of-careAUGUST 05, 2024 -Since the first immunotherapy drug to boost the body's immune response against advanced lung cancer was introduced in the United States in 2015, survival rates of patients with the disease have improved significantly.That's the conclusion of a recent real-world study published by Wiley online in CANCER, a peerreviewed journal of the American Cancer Society.